© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Valeant Acquisition of Salix Pharmaceuticals
Posted 27th February 2015

Valeant Acquisition of Salix Pharmaceuticals

NULL

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Valeant Acquisition of Salix Pharmaceuticals
Image

Valeant Acquisition of Salix Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion. The transaction was approved by the Boards of Directors of both companies. 

Salix Pharmaceuticals is a widely recognized gastrointestinal market leader with a portfolio of 22 total products, including well-known prescription brands Xifaxan, Uceris, Relistor, and Apriso, as well as a strong near- term pipeline of innovative, new assets. 

“Salix’s market-leading gastrointestinal franchise is an ideal strategic fit for Valeant’s diversified portfolio of specialty products,” said J. Michael Pearson, Valeant’s chairman and chief executive officer. “The growing GI market has attractive fundamentals, and Salix has a portfolio of terrific products that are outpacing the market in terms of volume growth and a promising near-term pipeline of innovative products. With strong brand recognition among specialist GI prescribers, a highly rated specialty sales force, and a significant product and commercial presence across the undertreated and underserved gastrointestinal market, this acquisition offers a compelling opportunity for Valeant to create a strong platform for growth and business development.” 

Thomas W. D’Alonzo, Chairman of the Board and Acting Chief Executive Officer of Salix, stated, “We are pleased to have reached an agreement with Valeant, which is a logical partner and importantly, creates immediate value for our shareholders. Combining Salix’s leading market position in gastroenterology with Valeant’s scale and resources will create a stronger and more diverse business committed to providing better health solutions to health care providers and their patients. We are proud of the accomplishments of our Salix team. Together, we have built our company into the leading gastrointestinal specialty pharmaceutical company, providing solutions for patients and healthcare providers. We look forward to working with the Valeant team to ensure a smooth transition.”

To find out more information about either company, please visit www.valeant.com or www.salix.com.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Non-Harmonious Ends to Congruous Beginnings
Leadership
27/07/2015Non-Harmonious Ends to Congruous Beginnings

As parties enter into mergers, acquisitions, joint ventures or any sort of corporate deal, there is often an overriding sense of harmony that this is a win-win scenario. However, perceived wisdom is that the success of any M&A activity can in fact be a double

Read Full PostRead - Eye Icon
Blockchain Pioneers Secure Success!
News
26/07/2022Blockchain Pioneers Secure Success!

The use of IT solutions within the business world is nothing new, but the blockchain offers a wealth of opportunity that many businesses have not even begun to consider.

Read Full PostRead - Eye Icon
The Global Tax [r]Evolution
Finance
14/10/2015The Global Tax [r]Evolution

One of the consequences of operating in an increasingly globalised and digitalised world, is that borders blur and taxing rights between countries become a hotly contested topic.

Read Full PostRead - Eye Icon
The Role of Ventilation Systems in Adapting Business Facilities for Hybrid Work Models
News
21/10/2024The Role of Ventilation Systems in Adapting Business Facilities for Hybrid Work Models

As more businesses begin to embrace the hybrid work model, the importance of adapting physical office spaces to ensure health, safety, and productivity continues to rise. Among other factors, efficient ventilation systems play a crucial role in this adaptation

Read Full PostRead - Eye Icon
Six Benefits of A VPN
News
22/03/2023Six Benefits of A VPN

Whether you are running an online business or simply just a consumer trying to have the best experience on the internet possible, things are only sometimes plain sailing.

Read Full PostRead - Eye Icon
Business Beyond the Bottom Line: A New Era of Enterprise
News
12/08/2024Business Beyond the Bottom Line: A New Era of Enterprise

Business Beyond the Bottom Line: A New Era of Enterprise Picture credit A paradigm shift is underway in the rapidly evolving landscape of modern business. Companies are increasingly recognizing that success is not solely defined by financial metrics but by a b

Read Full PostRead - Eye Icon
Providing TailorMade Solutions for Your Business
Strategy
20/12/2017Providing TailorMade Solutions for Your Business

Horev & Co. Law Office is a boutique law firm offering its clients individually tailored legal services in various commercial fields.

Read Full PostRead - Eye Icon
10 Benefits of Studying Public Health
News
10/05/202410 Benefits of Studying Public Health

Image Source Public health plays a pivotal role in shaping the well-being of local communities as well as global populations. Its core aim is to promote community health, prevent diseases, and extend life expectancy through organized efforts and informed choic

Read Full PostRead - Eye Icon
Swiss Excellence in Business Aviation
Innovation
10/11/2017Swiss Excellence in Business Aviation

Swiss Excellence in Business Aviation



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow